1. Independent and Co-morbid HIV Infection and Meth Use Disorders on Oxidative Stress Markers in the Cerebrospinal Fluid and Depressive Symptoms
- Author
-
Marla J. Berry, Sody Munsaka, Xiaosha Pang, Linda Chang, and Jun Panee
- Subjects
Male ,Aging ,medicine.medical_specialty ,Amphetamine-Related Disorders ,Immunology ,Neuroscience (miscellaneous) ,HIV Infections ,medicine.disease_cause ,Article ,Methamphetamine ,chemistry.chemical_compound ,Cerebrospinal fluid ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,Depression (differential diagnoses) ,Psychiatric Status Rating Scales ,Pharmacology ,chemistry.chemical_classification ,Depression ,business.industry ,Glutathione peroxidase ,Meth ,Glutathione ,Middle Aged ,Oxidative Stress ,Endocrinology ,chemistry ,Dementia ,Female ,business ,Biomarkers ,Oxidative stress ,medicine.drug - Abstract
Both HIV infection and Methamphetamine (Meth) use disorders are associated with greater depressive symptoms and oxidative stress; whether the two conditions would show additive or interactive effects on the severity of depressive symptoms, and whether this is related to the level of oxidative stress in the CNS is unknown. 123 participants were evaluated, which included 41 HIV-seronegative subjects without substance use disorders (Control), 25 with recent (
- Published
- 2015
- Full Text
- View/download PDF